Ammonia Solution, Strong

Ammonia Solution, Strong

SCHEMBL6994460

N.O=c1oc2ccccc2cc1C(F)(F)F

nearest known ligand 0.53

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HPGD P15428 5/20 0.53
SMN1; SMN2 Q16637 4/20 0.53
TYR P14679 1/20 0.53
DAO P14920 1/20 0.53
AKR1B1 P15121 1/20 0.53
POLB P06746 1/20 0.53
MAOB P27338 7/20 0.50
KDM4E B2RXH2 5/20 0.50
ALDH1A1 P00352 5/20 0.50
RAB9A P51151 4/20 0.50
CA12 O43570 3/20 0.49
CA9 Q16790 3/20 0.49
CA1 P00915 2/20 0.49
CA3 P07451 1/20 0.49
TSHR P16473 1/20 0.49
CA4 P22748 1/20 0.49
CA6 P23280 1/20 0.49
CA5A P35218 1/20 0.49
CA7 P43166 1/20 0.49
GPR35 Q9HC97 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7544470 0.98 HPGD (0.55) HPGDSMN1; SMN2TYRDAOAKR1B1
SCHEMBL383681 0.98 HPGD (0.55) HPGDSMN1; SMN2TYRDAOAKR1B1
Dimethylamine SCHEMBL5140932 0.92 HPGD (0.49) HPGDSMN1; SMN2TYRDAOAKR1B1
Benzyl Alcohol SCHEMBL333772 0.85 MAOB (0.48) HPGDSMN1; SMN2TYRDAOAKR1B1
SCHEMBL18554665 0.84 HPGD (0.56) HPGDSMN1; SMN2TYRDAOAKR1B1
SCHEMBL22590858 0.80 RAB9A (0.57) HPGDSMN1; SMN2TYRDAOAKR1B1
SCHEMBL837687 0.80 HPGD (0.55) HPGDSMN1; SMN2TYRDAOAKR1B1
SCHEMBL15842660 0.80 HPGD (0.55) HPGDSMN1; SMN2TYRDAOAKR1B1
SCHEMBL24312138 0.77 HPGD (0.51) HPGDSMN1; SMN2TYRDAOAKR1B1
SCHEMBL15842332 0.77 PGR (0.43) HPGDMAOBKDM4EALDH1A1GAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6555330-B1 Identifying a compound which modulates apoptosis in transformed cells using a cellular extract from a transformed cell that comprises an apoptotic machinery and a signal capable of activating the apoptotic machinery COLD SPRING HARBOR LABORATORY 2003-04-29 US disclosed
EP-1268414-A1 CERAMIDE DERIVATIVES AND METHOD OF USE The Liposome Company, Inc. (US) 2003-01-02 EP disclosed
EP-1269193-A2 A LYSOSOMAL PEPSTATIN-INSENSITIVE PROTEINASE AS BIOMARKER FOR BREAST CANCER Research Foundation for Mental Hygiene, Inc. (US) 2003-01-02 EP disclosed
WO-2001072701-A1 CERAMIDE DERIVATIVES AND METHOD OF USE THE LIPOSOME COMPANY, INC. (US) 2001-10-04 WO disclosed
WO-2001069260-A2 A LYSOSOMAL PEPSTATIN-INSENSITIVE PROTEINASE AS A NOVEL BIOMARKER FOR DETECTING AND DIAGNOSING BREAST CANCER RESEARCH FOUNDATION FOR MENTAL HYGIENE, INC. (US) 2001-09-20 WO disclosed
US-20010006793-A1 MODULATORS OF EUKARYOTIC CASPASES THOMAS JEFFERSON UNIVERSITY 2001-07-05 US disclosed